NSUN2 and neoplasm: Evaluation of subcutaneous tumour volume and their growth curves showed that although the differences between the NC‐ and NSUN2‐overexpressing groups were not significant after lapatinib treatment, the size of NSUN2‐overexpressing tumours was significantly reduced compared with the untreated NSUN2 group after lapatinib treatment (Figure 7B–D).